C66Taxane-rechallenge in HER2-positive breast cancer patients who develop an oligo-progression during pertuzumab-trastuzumab maintenance therapy
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI